1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

16 Jun 2021
Admin
News Article

Glenmark Launches Tiogiva Tiotropium Bromide Dry Powder Inhaler In Uk

Glenmark Pharmaceuticals Has Launched A Bioequivalent Version Of Tiotropium Bromide Dry Powder Inhaler (Dpi) Under The Brand Name &Ndash; Tiogiva, In The Uk For The Treatment Of Chronic Obstructive Pulmonary Disease (Copd).According To Data From Iqvia, Tiotropium Dpi Had A Market Size Of $ 450 Million In The Eu In The 12 Month Period Ended September 2020.Glenmark&Rsquo;S Subsidiary, Glenmark Pharmaceuticals Europe Had Entered Into A Strategic, Exclusive In-Licensing Arrangement For Marketing Generic Tiotropium Bromide Dpi In Western Europe And The Uk In August 2018. Glenmark Is Planning Subsequent Launches Of The Product Across Markets In Western Europe Under The Brand Name Tiogiva In Ireland, Sweden, Finland And Norway; Tavulus In Denmark, Spain, And Netherlands; And Tiotropium Glenmark In Germany.Tiotropium Bromide Dpi Is A Bioequivalent Version Of Boehringer Ingelheim&Rsquo;S Spiriva Handihaler And Is Used In The Treatment Of Copd.This Is The Second Inhalation Product In-Licensed By Glenmark For The European Market After Stalpex (Fluticasone/ Salmeterol) Dry Powder Inhaler.&Ldquo;We Are Glad To Introduce Tiogiva, One Of The First Bioequivalent Drugs To Be Launched In Europe For Treatment Of Copd. Respiratory Medicine Is A Key Area Of Focus For Glenmark And The Launch Of This Product Will Enable Us To Improve Access To Copd Treatment By Providing An Effective And High-Quality Treatment Option To Patients In The Uk And Western Europe,&Rdquo; Said Achin Gupta, Evp &Amp; Business Head Of Emea-L, Glenmark Pharmaceuticals.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!